Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials

Fig. 6

Grade ≥ 3 adverse events network meta-analysis results. A Schematic diagram showing the network map for the treatments included in the analysis. B Rankogram showing the ranking probabilities for the least odds of causing adverse events for each treatment. C Forest plot showing each trial effect size and confidence interval as well as the pooled effect size. D Bias-adjusted funnel plot showing each treatment separately

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us